Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Ocular Implants Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21251

Download Sample Report
Published On

June 2021

Total pages

173

About the Report

THE HUMAN EYE IS PROTECTED WITH THE HELP OF PHYSIOLOGICAL AND ANATOMICAL BARRIERS. THESE HELP IN BLOCKING THE ENTRY OF XENOBIOTICS AND LOWER THE BIOAVAILABILITY OF THERAPEUTIC AGENTS. INTERIOR AND POSTERIOR OCULAR DISORDER NEED'S FREQUENT ADMINISTRATION OF TOPICAL EYE DROP FORMULATION AND INTRAVITREAL INJECTIONS TO MAINTAIN EFFECTIVE TISSUE DRUG LEVELS. OCULAR IMPLANTS ARE THE BEST SUITABLE SOLUTION AVAILABLE FOR PATIENT'S SUFFERING FROM EYE DISORDER. OCULAR IMPLANTS LOADED WITH DRUG CAN RELEASE ACTIVE THERAPEUTIC AGENTS AND UNINTERRUPTEDLY MAINTAIN DRUG CONCENTRATIONS AT THE DESIRED SITE OF ACTION. OTHER FORMS OF OCULAR IMPLANTS ARE INTRA-OCULAR LENSES, WHICH INCREASE SHARPNESS OF VISION, AND ARE FREQUENTLY INSERTED AFTER THE PATIENT GO THROUGH A CATARACT SURGERY. THESE ARE USUALLY TRANSPARENT, TOLERABLE MATERIALS OF AN APPROPRIATE SIZE, POWER, AND SHAPE. OCULAR IMPLANTS CAN ALSO BE USED FOR PROSTHETIC PURPOSES. THESE CAN HELP IMPROVING AN INJURED PERSON'S APPEARANCE. PROSTHETIC EYES ARE AN ARTIFICIALLY MADE SHELL THAT COVERS THE STRUCTURE IN THE EYE SOCKET. IMPLANTING OF A PROSTHETIC EYE IS CALLED OCULAR PROSTHESIS. DISEASES SUCH AS GLAUCOMA, INFECTION OR EYE TUMOURS CAN LEAD TO THE NEED OF REMOVAL OF ONE'S EYE.

BASED ON PRODUCT, THE OCULAR IMPLANTS MARKET IS SEGMENTED INTO INTRAOCULAR LENSES, CORNEAL IMPLANTS, ORBITAL IMPLANTS, GLAUCOMA IMPLANTS, OCULAR IMPLANTS, AND OTHERS. THE INTRALOCULAR IMPLANTS SEGMENT WAS VALUED AT USD XX BILLION IN 2020 AND IS LIKELY TO REACH USD XX BILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027. BASED ON MATERIAL, OCULAR IMPLANTS CAN BE INTEGRATED OR NON-INTEGRATED. INTEGRATED OCULAR IMPLANTS FURTHER INCLUDE ALUMINIUM OXIDE, HYDROXYAPATITE, AND OTHERS. NON-INTEGRATED OCULAR IMPLANTS FURTHER INCLUDE ACRYLIC, GLASS, AND SILICON. ACRYLIC ACCOUNTED FOR A MARKET VALUATION OF USD XX BILLION IN 2020.

BASED ON APPLICATION, OCULAR IMPLANTS MARKET IS SEGMENTED INTO GLAUCOMA SURGERY, DRUG DELIVERY, AESTHETICS, OCULOPLASTY, AGE-RELATED MUSCULAR DEGENERATION AND OTHERS. THE GLAUCOMA SURGERY SEGMENT ACCOUNTED FOR MAXIMUM SHARE IN 2020. BASED ON END-USER, THE MARKET IS SEGMENTED INTO HOSPITALS, SPECIALTY CLINICS, EYE INSTITUTES AND OTHERS. THE HOSPITALS SEGMENT WAS VALUED AT USD XX BILLION IN 2020 AND IS LIKELY TO REACH USD XX BILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027.

FOR A BETTER UNDERSTANDING OF THE MARKET AND ADOPTION OF THE PROCEDURE, THE REPORT PROVIDES DETAILED ANALYSIS FOR MAJOR REGIONS INCLUDING NORTH AMERICA (US, CANADA, AND REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UK AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES A MAJOR MARKET FOR THE OCULAR IMPLANTS INDUSTRY AND GENERATED REVENUE OF USD XX BILLION IN 2020 OWING TO THE PRESENCE OF WELL-ESTABLISHED PLAYERS IN THE REGION, RISING HEALTHCARE INVESTMENT BY THE COMPANIES, ETC.

SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE NOVARTIS AG, JOHNSON AND JOHNSON, PFIZER INC., PORIFEROUS LLC, NOVAMED LTD, NETWORK MEDICAL PRODUCTS LTD., BAUSCH AND LOMB INCORPORATED, STAAR SURGICAL, CARL ZEISS MEDITEC AG, MOCHER GMBH. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.

Scope of the Report

Products

The human eye is protected with the help of physiological and anatomical barriers.

Companies

NOVARTIS AG

JOHNSON AND JOHNSON

PFIZER INC.

PORIFEROUS LLC

NOVAMED LTD

NETWORK MEDICAL PRODUCTS LTD.

BAUSCH AND LOMB INCORPORATED

STAAR SURGICAL

CARL ZEISS MEDITEC AG

MOCHER GMBH

Table of Contents

1 MARKET INTRODUCTION

1.1 MARKET DEFINITIONS

1.2 OBJECTIVE OF THE STUDY

1.3 LIMITATION

1.4 STAKE HOLDERS

1.5 CURRENCY USED IN REPORT

1.6 SCOPE OF THE OCULAR IMPLANTS MARKET STUDY

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 RESEARCH METHODOLOGY FOR THE OCULAR IMPLANTS MARKET

2.1.1 MAIN OBJECTIVE OF THE OCULAR IMPLANTS MARKET

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT

6.1 INTRAOCULAR LENSES

6.2 CORNEAL IMPLANTS

6.3 ORBITAL IMPLANTS

6.4 GLAUCOMA IMPLANTS

6.5 OCULAR PROSTHESIS

6.6 OTHERS

7 MARKET INSIGHTS BY MATERIAL

7.1 NON-INTEGRATED IMPLANTS

7.1.1 ACRYLIC

7.1.2 GLASS

7.1.3 SILICON

7.2 INTEGRATED IMPLANTS

7.2.1 ALUMINUM OXIDE

7.2.2 HYDROXYAPATITE

7.2.3 OTHERS

8 MARKET INSIGHTS BY APPLICATION

8.1 GLAUCOMA SURGERY

8.2 DRUG DELIVERY

8.3 AESTHETICS

8.4 OCULOPLASTY

8.5 AGE-RELATED MUSCULAR DEGENERATION

8.6 OTHERS

9 MARKET INSIGHTS BY END-USER

9.1 HOSPITALS

9.2 SPECIALTY CLINICS

9.3 EYE INSTITUTES

9.4 OTHERS

10 MARKET INSIGHTS BY REGION

10.1 NORTH AMERICA OCULAR IMPLANTS MARKET

10.1.1 UNITED STATES

10.1.2 CANADA

10.1.3 REST OF NORTH AMERICA

10.2 EUROPE OCULAR IMPLANTS MARKET

10.2.1 UNITED KINGDOM

10.2.2 GERMANY

10.2.3 FRANCE

10.2.4 SPAIN

10.2.5 ITALY

10.2.6 REST OF EUROPE

10.3 ASIA-PACIFIC OCULAR IMPLANTS MARKET

10.3.1 CHINA

10.3.2 JAPAN

10.3.3 INDIA

10.3.4 AUSTRALIA

10.3.5 REST OF ASIA-PACIFIC

10.4 REST OF THE WORLD OCULAR IMPLANTS MARKET

11 LEGAL AND REGULATORY FRAMEWORK

12 DEMAND AND SUPPLY SIDE ANALYSIS

12.1 DEMAND SIDE ANALYSIS

12.2 SUPPLY SIDE ANALYSIS

12.2.1 TOP PRODUCT LAUNCHES

12.2.2 TOP BUSINESS PARTNERSHIPS

12.2.3 TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

12.2.4 TOP MERGER AND ACQUISITIONS

13 VALUE CHAIN ANALYSIS

14 OCULAR IMPLANTS MARKET TRENDS & INSIGHTS

15 OCULAR IMPLANTS MARKET DYNAMICS

15.1 DRIVERS

15.2 CHALLENGES

15.3 IMPACT ANALYSIS

15.4 OPPORTUNITY

16 COMPETITIVE SCENARIO

16.1 OCULAR IMPLANTS MARKET SHARE, BY COMPANY 2020

17 COMPANY PROFILED

17.1 NOVARTIS AG

17.2 JOHNSON AND JOHNSON

17.3 PFIZER INC.

17.4 PORIFEROUS LLC

17.5 NOVAMED LTD

17.6 NETWORK MEDICAL PRODUCTS LTD

17.7 BAUSCH AND LOMB INCORPORATED

17.8 STAAR SURGICAL

17.9 CARL ZEISS MEDITEC AG

17.10 MOCHER GMBH

18 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022